New combo therapy may help newly diagnosed diabetics go Drug-Free for a year

NCT ID NCT01471808

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding oral diabetes drugs (metformin/pioglitazone or sitagliptin) to a short-term insulin pump can improve long-term blood sugar control and help newly diagnosed type 2 diabetes patients achieve remission. 264 participants who were newly diagnosed, not on any diabetes medication, and had moderate to high blood sugar were enrolled. The main goal was to see how many could maintain normal blood sugar without medication for one year after the short intensive treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.